Aprea Therapeutics Inc
NASDAQ:APRE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aprea Therapeutics Inc
NASDAQ:APRE
|
US |
|
C
|
CITIC Ltd
XMUN:CPF
|
CN |
|
IDP Education Ltd
ASX:IEL
|
AU |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
Sibanye Stillwater Ltd
OTC:SBYSF
|
ZA |
|
Yancoal Australia Ltd
HKEX:3668
|
AU |
|
InsuraGuest Technologies Inc
XTSX:ISGI
|
CA |
|
GK TNS Energo PAO
MOEX:TNSE
|
RU |
|
A
|
Art Design & Communication JSC
VN:ADC
|
VN |
|
Tokyo Ohka Kogyo Co Ltd
TSE:4186
|
JP |
|
G
|
GoGold Resources Inc
OTC:GLGDF
|
CA |
|
Kingdee International Software Group Co Ltd
HKEX:268
|
CN |
|
C
|
Coherus Oncology Inc
F:8C5
|
US |
|
G
|
Goldex Resources Corp
OTC:GDXRF
|
CA |
|
L
|
Leonardo SpA
DUS:FMNB
|
IT |
Bankruptcy Probability
Aprea Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aprea Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aprea Therapeutics Inc
NASDAQ:APRE
|
6.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
196.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aprea Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aprea Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.